In the evolving landscape of clinical research, basket trials are gaining prominence as a flexible and efficient method of evaluating new therapies. If you’re asking, “What is a basket trial?” you are in the right place. This comprehensive guide will demystify the concept of basket trials, their benefits, and how they fit into the broader context of drug development.
A basket trial is a type of clinical trial designed to evaluate the effectiveness of one or more investigational drugs on multiple tumors or diseases that share specific genetic or molecular characteristics. This approach allows researchers to “basket” together different patient populations under a single protocol, thereby streamlining the evaluation of therapies that might work across various conditions.
The adoption of basket trials has several advantages, particularly in the context of personalized medicine. Here are some compelling reasons why researchers opt for this design:
Basket trials allow for a more efficient evaluation of drugs, enabling sponsors to determine their efficacy across multiple indications without the necessity of separate studies for each disease. This can significantly reduce the development timeline and costs.
By targeting patients with specific genetic profiles rather than a single disease type, basket trials can enhance recruitment efforts, allowing researchers to enroll eligible patients more quickly and effectively.
These trials can provide valuable real-world evidence on how well a treatment works across diverse patient populations, which is especially crucial for targeted therapies.
To understand the full scope of what is a basket trial, it is useful to compare it with other clinical trial designs, such as platform trials and adaptive trial designs.
While both designs offer flexibility, platform trials evaluate multiple treatments simultaneously, often with multiple objectives, whereas basket trials focus on a specific treatment across multiple disease types. For a deeper look into the modern methodologies in clinical trials, including platform trials, check out our article on what are platform trials in drug development.
Like basket trials, adaptive trials allow for modifications during the study based on interim results. However, basket trials are primarily focused on assessing a single treatment in varying contexts, while adaptive trials may evaluate several treatments and change the research based on patient responses. Learn more about what are adaptive trial design types here.
Basket trials provide a cost-effective and efficient way to evaluate the effectiveness of a drug across various conditions, supporting personalized medicine initiatives and speeding up the drug approval process.
Basket trials can assess treatments for various diseases as long as the conditions share the same underlying genetic or molecular characteristics. This encompasses multiple cancer types and may include other therapeutic areas as well.
Engaging a Contract Research Organization (CRO) is crucial for ensuring compliance with regulatory guidelines and optimizing trial design. For insights on the timing to involve a CRO for adaptive trial design, refer to our resource on when to use a CRO for adaptive trial design.
With their innovative approach, basket trials represent a significant advancement in clinical trial design, addressing the complexities of personalized medicine and the demands of modern drug development. By enabling researchers to evaluate multiple indications in one trial, basket trials not only expedite the approval process but also pave the way for more personalized treatment options.
If you’re interested in learning more about how InfinixBio can assist your organization with preclinical research and support in clinical trials, do not hesitate to contact us today. Together, we can accelerate your journey in the drug development landscape.
Our experienced lab team is here to help. Reach out today to learn more.
Back to Glossary